The Foundation is pleased to announce the start of a new clinical drug trial for ALS at the Lois Insolia ALS Clinic at the Les Turner ALS Research and Patient Center at Northwestern Medicine. VITALITY-ALS is a Phase 3 clinical trial designed to evaluate the safety and effectiveness of tirasemtiv, an investigational drug candidate under evaluation for the potential treatment of ALS. The objective of the clinical trial is to assess the effect of tirasemtiv versus placebo on respiratory function. People with ALS in Illinois who wish to be considered for this trial should contact the Lois Insolia ALS Clinic at [email protected].
